Xylem XYL Compensation and benefits
Compensation and benefits at other companies
Other financials
Where this comes from
Reported directly by Xylem in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The source filing: Xylem’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 11:53 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001524472-26-000110
Share-based compensation expense was $12 million and $25 million during the three and six months ended June 30, 2026, respectively, and $13 million and $25 million during the three and six months ended June 30, 2025, respectively. The unrecognized compensation expense related to our stock options, restricted stock units and performance share units was $16 million, $56 million and $28 million, respectively, at June 30, 2026 and is expected to be recognized over a weighted average period of 2.2, 2.2 and 2.0 years, respectively. The amount of cash received from the exercise of stock options was $2 million and $8 million for the six months ended June 30, 2026 and 2025, respectively.
ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FAQ
- What is Xylem's compensation and benefits?
- Xylem (XYL) reported compensation and benefits of $12M in Q2 2026.
- How has Xylem's compensation and benefits changed year-over-year?
- Xylem's compensation and benefits decreased by 7.7% year-over-year, from $13M to $12M.
- What does compensation and benefits mean?
- Total employee-related costs including salaries, wages, bonuses, commissions, stock-based compensation, health insurance, retirement contributions, and payroll taxes.
Ask your AI about Xylem's compensation and benefits.
Connect your AI assistant and compare it to peers, right in your chat.
